查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1924719

O型臂市场依采购模式、服务类型、应用、最终用户和通路划分－2026-2032年全球预测

O-arm Market by Purchase Model, Service Type, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，O 型臂市场价值将达到 3.2009 亿美元，到 2026 年将成长到 3.647 亿美元，到 2032 年将达到 8.245 亿美元，年复合成长率为 14.47%。

关键市场统计数据
基准年 2025 3.2009亿美元
预计年份：2026年 3.647亿美元
预测年份 2032 8.245亿美元
复合年增长率 (%) 14.47%

O型臂影像系统的策略应用：外科专科临床价值提案、技术定位、报销考量与应用驱动因素框架

O型臂术中影像系统已成为外科团队的核心考量因素，旨在将即时影像与导航和手术精准性相结合。现代医院和门诊手术中心在评估这些系统时，不仅关注影像质量，还关注其与导航平台、机器人助手和电子病历工作流程的整合度。如何在降低再次手术率和缩短手术时间等临床结果与手术室周转率、人员能力和长期维护性等运作因素之间取得平衡，变得日益重要。

术中影像技术正经历变革性转变，人工智慧导航、机器人整合、先进显像模式以及跨部门诊疗路径重塑将带来变革。

术中影像领域正经历变革时期，其驱动力源自于影像硬体的改进、先进视觉化软体的进步以及机器学习引导工具的融合。儘管影像撷取的精确度和速度有所提升，但更大的变革在于系统正朝着在手术过程中提供情境化临床资讯的方向发展，使团队能够根据结构化的影像输出进行即时调整。持续的软体演进、模组化硬体设计以及增强的连接性，正为与导航平台和手术全期数据系统的整合开闢新的途径。

评估美国2025年关税对O型臂采购、全球供应链、零件成本、医院资本规划和合约策略的累积影响

近期影响关税的政策倡议，为手术室设备采购计画、供应链设计和定价策略引入了新的变数。关税调整不仅影响整套系统的到岸成本，还会影响关键子组件和耗材（这些组件和耗材可能从国际采购）的经济效益。采购团队正在透过重新评估供应商多元化、协商延长服务协议以保障设备运作，以及探索能够减轻近期资本负担的资金筹措方案来应对这些变化。

细分市场分析：了解应用领域、最终用户类型、购买模式、服务交付形式和通路对采用趋势和生命週期经济学的影响

透过对 O-Arm 生态系统的应用、最终用户、采购模式、服务类型和分销管道进行分析，揭示了不同临床环境下的采用模式和支援需求存在差异。按应用领域划分，O-Arm 的应用主要集中在神经外科、整形外科、脊椎外科和创伤外科，其中神经外科又细分为功能性手术、肿瘤切除和血管介入。整形外科的应用主要集中在骨折固定和关节关节重建方面，而脊椎外科则分为微创手术和开放式脊椎手术。微创手术又进一步分为内视镜手术和经皮手术。创伤应用主要集中在下肢和上肢创伤，每个创伤都有其独特的成像和工作流程要求。

区域趋势与应用模式：美洲、欧洲、中东和非洲以及亚太地区的基础设施发展、报销体係以及决定临床应用轨蹟的因素

区域趋势对采购方式、临床训练系统和报销架构有显着影响，进而影响术中影像系统的应用。在美洲，医疗系统和私人医院优先考虑整合解决方案，以支援高手术量并符合综合支付倡议。同时，在手术配置和报销机制能够实现当日手术的地区，门诊应用率正在不断提高。基础设施建设的进展以及学术机构在某些大都会圈的集中，加速了先进成像技术的早期临床检验和应用。

专注于产品差异化、策略联盟、服务生态系统和市场进入策略的竞争考察，旨在推动永续的商业性优势。

术中成像领域的主要企业正在寻求独特的策略，以实现产品差异化并建立长期的客户关係。一些企业优先考虑硬体创新，致力于提高影像清晰度、缩短撷取时间和简化无菌区管理。另一些企业则专注于软体生态系统，以增强导航功能、3D视觉化效果以及与电子病历的互通性。还有一些企业则优先考虑服务融资结构，以降低中型医院和门诊手术中心采用该技术的门槛。

为产业领导者提供切实可行的策略建议，以加速临床应用、降低整体拥有成本、增强售后市场收入并降低供应风险。

业界领导者应优先考虑一系列切实可行的倡议，以加速临床应用，同时保障营运利润和病患疗效。首先，使产品蓝图与互通性标准保持一致，并与导航系统、手术机器人和手术全期IT平台建立清晰的整合路径，以减少应用阻力，提升临床团队对产品价值的认知。其次，拓展灵活的商业模式，包括经营性租赁、分期付款购买选项以及与运作和疗效指标挂钩的综合服务协议，以应对资金限制和采购偏好。

一套透明的调查方法，清楚地概述了用于得出战略洞见的初级和二级研究、专家检验、分析框架和品管。

本报告的分析方法采用结构化的多源资料收集方法，结合了原始定性资料和严谨的二手检验。原始研究包括对临床医生、生物医学工程师、采购主管和服务经理进行半结构式访谈，以了解设备整合、临床工作流程和支援期望等方面的实际考量。访谈通讯协定强调开放式问题，旨在挖掘定量资料无法捕捉的临床价值、员工培训和决策因素的细緻观点。

一份权威的执行摘要，概述了技术整合和服务交付方面的策略挑战、实施障碍、机会领域和切实可行的后续步骤。

整合临床、商业性和营运观点，凸显了术中成像解决方案相关相关人员的明确策略要务。首先，临床认可取决于与现有手术流程的实际整合以及手术可靠性的可衡量提升。其次，商业性成功越来越依赖灵活的采购和服务模式，以减轻资金压力并确保可预测的运作。第三，随着全球政策和零件供应的不稳定性造成上游风险，供应链韧性和合约创新正从后勤部门考量上升到董事会层面的优先事项。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：O型臂市场采购模式

  • 租
    • 融资租赁
    • 经营租赁
  • 购买

第九章 依服务类型分類的O型臂市场

  • 内部服务
  • 外包服务

第十章 O型臂市场：依应用领域划分

  • 神经外科
    • 功能性
    • 肿瘤切除
    • 血管外科
  • 整形外科手术
    • 骨折固定
    • 关节重建
  • 脊椎手术
    • 微创脊椎手术
      • 内视镜手术
      • 经皮
    • 开放式脊椎手术
  • 创伤外科

第十一章 依最终用户分類的O型臂市场

  • 门诊手术中心
  • 诊所
    • 综合诊所
    • 专科诊所
  • 医院

第十二章 依分销通路分類的O型臂市场

  • 离线
  • 在线的

第十三章 按地区分類的O型臂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 依组别分類的O型臂市场

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国O型臂市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国O型臂市场

第十七章：中国的O型臂市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Amico Corporation
  • Baxter International Inc.
  • BeaconMedaes LLC
  • Brandon Medical Co. Ltd.
  • CV Medical LLC
  • Dragerwerk AG & Co. KGaA
  • Fuji Booms Co., Ltd.
  • Getinge AB
  • Hipac Healthcare Pty Ltd.
  • KARL STORZ SE & Co. KG
  • Mediland Enterprise Corporation
  • Olympus Corporation
  • Ondal Medical Systems GmbH
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Sigma Medical Systems, Inc.
  • Skytron LLC
  • Starkstrom Limited
  • STERIS plc
  • Stryker Corporation
  • TRUMPF Medizin Systeme GmbH
Product Code: MRR-7A380DA7C44D

The O-arm Market was valued at USD 320.09 million in 2025 and is projected to grow to USD 364.70 million in 2026, with a CAGR of 14.47%, reaching USD 824.50 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 320.09 million
Estimated Year [2026] USD 364.70 million
Forecast Year [2032] USD 824.50 million
CAGR (%) 14.47%

O-arm Imaging Systems Strategic Introduction Framing Clinical Value Propositions, Technological Positioning, Reimbursement Considerations, and Adoption Drivers across Surgical Specialties

O-arm intraoperative imaging systems have become a central consideration for surgical teams aiming to combine real-time imaging with navigation and procedural precision. Modern hospitals and ambulatory centers evaluate these systems not only for image quality but for how they integrate with navigation platforms, robotic assistants, and electronic health record workflows. The decision calculus increasingly balances clinical outcomes such as reduced revision rates and procedure time against operational factors including room turnover, staffing competency, and long-term serviceability.

Clinicians view the O-arm as an enabler of targeted interventions across neurosurgery, spine, orthopedic, and trauma specialties, while procurement leaders assess capital deployment alongside aftermarket commitments. As device makers expand software capabilities, interoperability and data governance have emerged as pivotal criteria for adoption. Consequently, understanding the device's role within the broader digital operating room ecosystem is essential for stakeholders prioritizing patient safety, reproducibility of surgical workflows, and measurable improvements in procedural efficiency.

Transformative Shifts Reshaping Intraoperative Imaging Through AI-Enabled Navigation, Robotics Integration, Enhanced Imaging Modalities, and Cross-Sector Care Pathway Redesign

The intraoperative imaging landscape is undergoing a transformative phase driven by the convergence of imaging hardware improvements, advanced visualization software, and machine learning-enabled guidance tools. Image acquisition fidelity and speed have improved, but the greater shift is toward systems that deliver contextual clinical intelligence during procedures, enabling teams to make real-time adjustments based on structured imaging outputs. Continuous software evolution, modular hardware design, and enhanced connectivity are creating new pathways for integration with navigation platforms and perioperative data systems.

Alongside technical progress, clinical practice is changing: minimally invasive techniques and hybrid surgical suites are pushing demand for compact, flexible imaging solutions that minimize disruption to care pathways. Service delivery models are evolving as well, with providers emphasizing uptime guarantees, predictable maintenance costs, and outcome-linked service contracts. These changes are prompting device manufacturers and channel partners to re-evaluate product roadmaps, aftermarket plans, and clinical support structures to remain relevant in a rapidly modernizing surgical environment.

Assessing the Cumulative Impact of United States Tariffs 2025 on O-arm Procurement, Global Supply Chains, Component Costs, Hospital Capital Planning, and Contracting Strategies

Recent policy actions affecting tariffs have introduced new variables into procurement planning, supply chain design, and pricing strategies for capital equipment used in the operating room. Tariff adjustments influence not only the landed cost of finished systems but also the economics of key subcomponents and consumables that may be sourced internationally. Procurement teams are responding by reassessing supplier diversification, negotiating extended-service commitments to protect uptime, and exploring financing structures that mitigate near-term capital strain.

The cascading operational implications extend to contract negotiations with distributors and original equipment manufacturers, where clauses addressing long lead times, currency exposure, and component scarcity are becoming more prevalent. Health systems and ambulatory centers are adjusting capital budgeting cycles and instituting stronger cross-functional governance between clinical, finance, and supply chain teams to preserve access to critical technologies while maintaining cost discipline. In short, tariff-related pressures are reshaping sourcing strategies and contract design without diminishing clinical demand for robust intraoperative imaging capabilities.

Segmentation Insights Revealing How Application Areas, End User Types, Purchase Models, Service Offerings, and Distribution Channels Influence Adoption and Lifecycle Economics

Disaggregating the O-arm ecosystem by application, end user, purchase model, service type, and distribution channel reveals differentiated adoption patterns and support requirements across clinical settings. When analyzed by application, the system is deployed across neurosurgery, orthopedic surgery, spine surgery, and trauma surgery, with neurosurgery further segmented into functional procedures, tumor resection, and vascular interventions. Orthopedic deployment centers on fracture fixation and joint replacement use cases, while spine surgery adoption is divided between minimally invasive spine surgery and open spine surgery, with minimally invasive approaches further classified into endoscopic and percutaneous techniques. Trauma applications concentrate on lower extremity trauma and upper extremity trauma, each carrying unique imaging and workflow demands.

Considering end users, adoption varies among ambulatory surgical centers, clinics, and hospitals. Ambulatory surgical centers differentiate between hospital-owned and independent operators; clinics split into multi-specialty and specialty-focused establishments; and hospitals fall into academic and community categories, each with distinct purchasing authority and clinical priorities. Purchase models influence acquisition strategies, with choices between leasing and purchase; leasing can be structured as finance lease or operating lease, whereas purchase options include direct purchase and installment payment. Service type drives total cost considerations and clinical uptime priorities, with options for in-house service or outsourced service, the latter provided either as OEM-supported or via third-party service partners. Distribution channels encompass direct sales, online channels, and third-party distributors, and online channels include marketplaces and OEM portals while third-party distributors may be local or national in scope. These layered segmentations collectively determine procurement timelines, training programs, capital allocation, and aftermarket commitments, shaping how stakeholders evaluate the technology across use cases and organizational structures.

Regional Dynamics and Adoption Patterns Across Americas, Europe Middle East & Africa, and Asia-Pacific Determining Infrastructure Readiness, Reimbursement, and Clinical Uptake Trajectories

Regional dynamics exert a significant influence over procurement approaches, clinical training pipelines, and reimbursement frameworks that affect the uptake of intraoperative imaging systems. In the Americas, health systems and private hospitals tend to prioritize integrated solutions that support busy procedural volumes and align with bundled payment initiatives, while ambulatory adoption is rising where procedure mix and reimbursement permit same-day workflows. Infrastructure readiness and concentration of academic centers in certain metropolitan areas accelerate early clinical validation and diffusion of advanced imaging capabilities.

In Europe, Middle East & Africa, variability in regulatory pathways, public procurement practices, and reimbursement structures creates a mosaic of adoption rates. Northern and Western European centers often drive innovation adoption through tight clinical networks and centralized purchasing consortia, whereas emerging markets in the region prioritize cost-effective configurations and service models that limit downtime. In Asia-Pacific, rapid investments in specialty hospitals and an emphasis on minimally invasive techniques are fostering demand, tempered by the need for local training programs and supply chain localization. Across regions, differences in capital allocation cycles, clinical guidelines, and workforce training determine the sequence and scale of deployments, necessitating tailored go-to-market and support strategies for manufacturers and channel partners.

Competitive Company Insights Emphasizing Product Differentiation, Strategic Partnerships, Service Ecosystems, and Go-to-Market Tactics That Drive Sustainable Commercial Advantage

Leading companies in the intraoperative imaging space pursue distinct strategies to differentiate product offerings and secure long-term customer engagements. Some organizations focus on hardware innovations that improve image clarity, reduce acquisition time, and simplify sterile field management, while others emphasize software ecosystems that enhance navigation, 3D visualization, and interoperability with electronic health records. A third cohort prioritizes service and financing constructs that lower barriers to adoption for mid-sized hospitals and ambulatory surgical centers.

Strategic partnerships and channel diversification are common responses to distribution and service challenges. Manufacturers are expanding OEM relationships, forming alliances with navigation and robotics firms, and developing third-party servicing arrangements to broaden coverage. Aftermarket revenue is increasingly significant, incentivizing companies to offer modular upgrades, subscription-based software features, and outcome-oriented service agreements. Competitive positioning also reflects investments in clinical evidence generation, with companies sponsoring peer-reviewed studies and building evidence libraries that demonstrate procedural benefits and workflow efficiencies.

Actionable Strategic Recommendations for Industry Leaders to Accelerate Clinical Adoption, Reduce Total Cost of Ownership, Strengthen Aftermarket Revenue, and Mitigate Supply Risk

Industry leaders should prioritize a set of pragmatic initiatives that accelerate clinical adoption while protecting operational margins and patient outcomes. First, align product roadmaps with interoperability standards and establish clear integration pathways with navigation systems, surgical robotics, and perioperative IT platforms, thereby reducing implementation friction and increasing perceived value among clinical teams. Second, expand flexible commercial models that include operating leases, installment purchasing options, and bundled service agreements tied to uptime and outcome metrics to address capital constraints and procurement preferences.

Third, invest in regionalized training programs and virtual simulation to shorten the clinician learning curve and facilitate confidence in minimally invasive and hybrid procedures. Fourth, fortify supply chains by diversifying component sourcing, increasing transparency in lead times, and negotiating protective contract terms that share tariff and currency risk with key partners. Finally, develop scalable aftermarket offerings-remote monitoring, predictive maintenance, and subscription software services-that create recurring revenue streams and strengthen long-term customer relationships. Implementing these priorities in concert will help companies convert clinical interest into durable adoption while mitigating commercial and operational risk.

Transparent Research Methodology Outlining Primary and Secondary Data Collection, Expert Validation, Analytical Frameworks, and Quality Controls Used to Derive Strategic Insights

The analysis underpinning this report used a structured, multi-source approach combining primary qualitative input and rigorous secondary validation. Primary research included semi-structured interviews with clinicians, biomedical engineers, procurement leaders, and service managers to capture real-world considerations around device integration, clinical workflows, and support expectations. Interview protocols emphasized open-ended questions to elicit nuanced perspectives on clinical value, staff training, and decision drivers that quantitative sources may not capture.

Secondary research cross-referenced regulatory filings, peer-reviewed clinical literature, device manuals, and public procurement documents to corroborate themes emerging from interviews. Analytical protocols included triangulation of qualitative inputs against documented device capabilities and service offerings, and scenario analysis to examine how changes in procurement policies and supply dynamics could influence organizational behavior. Quality controls included multiple rounds of peer validation, traceable sourcing for key assertions, and anonymized expert review to ensure conclusions are grounded in verifiable inputs and robust reasoning.

Conclusive Executive Synthesis Summarizing Strategic Imperatives, Adoption Barriers, Opportunity Areas, and Practical Next Steps for Technology Integration and Service Delivery

The synthesis of clinical, commercial, and operational perspectives highlights a clear set of strategic imperatives for stakeholders engaged with intraoperative imaging solutions. First, clinical acceptance depends on demonstrable integration with existing surgical workflows and measurable improvements in procedural reliability. Second, commercial success is increasingly tied to flexible acquisition and service models that mitigate capital pressures and ensure predictable uptime. Third, supply chain resilience and contractual innovation have moved from back-office considerations to board-level priorities as global policy and component availability create upstream risks.

Taken together, these themes underscore the need for coordinated actions across product development, clinical affairs, and commercial teams. Manufacturers that combine interoperable technology, compelling clinical evidence, and adaptive commercial structures will be well positioned to support diverse provider needs. Providers that align procurement, clinical training, and maintenance planning will extract greater value from investments in imaging capabilities, ultimately improving procedural consistency and patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. O-arm Market, by Purchase Model

  • 8.1. Leasing
    • 8.1.1. Finance Lease
    • 8.1.2. Operating Lease
  • 8.2. Purchase

9. O-arm Market, by Service Type

  • 9.1. In-House Service
  • 9.2. Outsourced Service

10. O-arm Market, by Application

  • 10.1. Neurosurgery
    • 10.1.1. Functional
    • 10.1.2. Tumor Resection
    • 10.1.3. Vascular
  • 10.2. Orthopedic Surgery
    • 10.2.1. Fracture Fixation
    • 10.2.2. Joint Replacement
  • 10.3. Spine Surgery
    • 10.3.1. Minimally Invasive Spine Surgery
      • 10.3.1.1. Endoscopic
      • 10.3.1.2. Percutaneous
    • 10.3.2. Open Spine Surgery
  • 10.4. Trauma Surgery

11. O-arm Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Clinics
    • 11.2.1. Multi Specialty Clinics
    • 11.2.2. Specialty Clinics
  • 11.3. Hospitals

12. O-arm Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. O-arm Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. O-arm Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. O-arm Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States O-arm Market

17. China O-arm Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Amico Corporation
  • 18.6. Baxter International Inc.
  • 18.7. BeaconMedaes LLC
  • 18.8. Brandon Medical Co. Ltd.
  • 18.9. CV Medical LLC
  • 18.10. Dragerwerk AG & Co. KGaA
  • 18.11. Fuji Booms Co., Ltd.
  • 18.12. Getinge AB
  • 18.13. Hipac Healthcare Pty Ltd.
  • 18.14. KARL STORZ SE & Co. KG
  • 18.15. Mediland Enterprise Corporation
  • 18.16. Olympus Corporation
  • 18.17. Ondal Medical Systems GmbH
  • 18.18. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 18.19. Sigma Medical Systems, Inc.
  • 18.20. Skytron LLC
  • 18.21. Starkstrom Limited
  • 18.22. STERIS plc
  • 18.23. Stryker Corporation
  • 18.24. TRUMPF Medizin Systeme GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL O-ARM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL O-ARM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL O-ARM MARKET SIZE, BY PURCHASE MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL O-ARM MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL O-ARM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL O-ARM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL O-ARM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL O-ARM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL O-ARM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA O-ARM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL O-ARM MARKET SIZE, BY LEASING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL O-ARM MARKET SIZE, BY LEASING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL O-ARM MARKET SIZE, BY LEASING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL O-ARM MARKET SIZE, BY FINANCE LEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL O-ARM MARKET SIZE, BY FINANCE LEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL O-ARM MARKET SIZE, BY FINANCE LEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL O-ARM MARKET SIZE, BY OPERATING LEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL O-ARM MARKET SIZE, BY OPERATING LEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL O-ARM MARKET SIZE, BY OPERATING LEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL O-ARM MARKET SIZE, BY PURCHASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL O-ARM MARKET SIZE, BY PURCHASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL O-ARM MARKET SIZE, BY PURCHASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL O-ARM MARKET SIZE, BY IN-HOUSE SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL O-ARM MARKET SIZE, BY IN-HOUSE SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL O-ARM MARKET SIZE, BY IN-HOUSE SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL O-ARM MARKET SIZE, BY OUTSOURCED SERVICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL O-ARM MARKET SIZE, BY OUTSOURCED SERVICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL O-ARM MARKET SIZE, BY OUTSOURCED SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL O-ARM MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL O-ARM MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL O-ARM MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL O-ARM MARKET SIZE, BY FUNCTIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL O-ARM MARKET SIZE, BY FUNCTIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL O-ARM MARKET SIZE, BY FUNCTIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL O-ARM MARKET SIZE, BY TUMOR RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL O-ARM MARKET SIZE, BY TUMOR RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL O-ARM MARKET SIZE, BY TUMOR RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL O-ARM MARKET SIZE, BY VASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL O-ARM MARKET SIZE, BY VASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL O-ARM MARKET SIZE, BY VASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL O-ARM MARKET SIZE, BY FRACTURE FIXATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL O-ARM MARKET SIZE, BY FRACTURE FIXATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL O-ARM MARKET SIZE, BY FRACTURE FIXATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL O-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL O-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL O-ARM MARKET SIZE, BY JOINT REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL O-ARM MARKET SIZE, BY SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL O-ARM MARKET SIZE, BY SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL O-ARM MARKET SIZE, BY SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL O-ARM MARKET SIZE, BY ENDOSCOPIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL O-ARM MARKET SIZE, BY ENDOSCOPIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL O-ARM MARKET SIZE, BY ENDOSCOPIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL O-ARM MARKET SIZE, BY PERCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL O-ARM MARKET SIZE, BY PERCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL O-ARM MARKET SIZE, BY PERCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL O-ARM MARKET SIZE, BY OPEN SPINE SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL O-ARM MARKET SIZE, BY OPEN SPINE SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL O-ARM MARKET SIZE, BY OPEN SPINE SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL O-ARM MARKET SIZE, BY TRAUMA SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL O-ARM MARKET SIZE, BY TRAUMA SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL O-ARM MARKET SIZE, BY TRAUMA SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL O-ARM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL O-ARM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL O-ARM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL O-ARM MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL O-ARM MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL O-ARM MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL O-ARM MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL O-ARM MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL O-ARM MARKET SIZE, BY MULTI SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL O-ARM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL O-ARM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL O-ARM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL O-ARM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL O-ARM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL O-ARM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL O-ARM MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL O-ARM MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL O-ARM MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL O-ARM MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL O-ARM MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL O-ARM MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL O-ARM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS O-ARM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 159. MIDDLE EAST O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 160. MIDDLE EAST O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL O-ARM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. GCC O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. GCC O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 203. GCC O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 204. GCC O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. GCC O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. GCC O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 207. GCC O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 208. GCC O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 209. GCC O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 211. GCC O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 212. GCC O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPEAN UNION O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 237. G7 O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. G7 O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 239. G7 O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 240. G7 O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. G7 O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. G7 O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 244. G7 O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 245. G7 O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 246. G7 O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. G7 O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 248. G7 O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 249. NATO O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. NATO O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 251. NATO O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 252. NATO O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. NATO O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 255. NATO O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 256. NATO O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 257. NATO O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 258. NATO O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. NATO O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 260. NATO O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL O-ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 268. UNITED STATES O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 269. UNITED STATES O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 270. UNITED STATES O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 271. UNITED STATES O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 272. UNITED STATES O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 273. UNITED STATES O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. CHINA O-ARM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. CHINA O-ARM MARKET SIZE, BY PURCHASE MODEL, 2018-2032 (USD MILLION)
  • TABLE 276. CHINA O-ARM MARKET SIZE, BY LEASING, 2018-2032 (USD MILLION)
  • TABLE 277. CHINA O-ARM MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. CHINA O-ARM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. CHINA O-ARM MARKET SIZE, BY NEUROSURGERY, 2018-2032 (USD MILLION)
  • TABLE 280. CHINA O-ARM MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2032 (USD MILLION)
  • TABLE 281. CHINA O-ARM MARKET SIZE, BY SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 282. CHINA O-ARM MARKET SIZE, BY MINIMALLY INVASIVE SPINE SURGERY, 2018-2032 (USD MILLION)
  • TABLE 283. CHINA O-ARM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. CHINA O-ARM MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA O-ARM MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)